靶向人类癌细胞中的致癌性SOX2：治疗应用 - Suppr | 超能文献

文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

靶向人类癌细胞中的致癌性SOX2：治疗应用 - Suppr | 超能文献

Targeting oncogenic SOX2 in human cancer cells: therapeutic application.

作者信息

Zhang Shizhen, Sun Yi

机构信息

Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, 48109, USA.

The Cancer Institute of the Second Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310029, China.

出版信息

Protein Cell. 2020 Feb;11(2):82-84. doi: 10.1007/s13238-019-00673-x.

DOI:10.1007/s13238-019-00673-x

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6954883/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fed/6954922/3b9ec09983a2/13238_2019_673_Fig1_HTML.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fed/6954922/3b9ec09983a2/13238_2019_673_Fig1_HTML.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fed/6954922/3b9ec09983a2/13238_2019_673_Fig1_HTML.jpg

相似文献

1

Targeting oncogenic SOX2 in human cancer cells: therapeutic application.靶向人类癌细胞中的致癌性SOX2：治疗应用

Protein Cell. 2020 Feb;11(2):82-84. doi: 10.1007/s13238-019-00673-x.

2

The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells.FBXW2-MSX2-SOX2 轴调节干细胞特性和癌细胞的耐药性。

Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20528-20538. doi: 10.1073/pnas.1905973116. Epub 2019 Sep 23.

3

SOX2 in cancer stemness: tumor malignancy and therapeutic potentials.SOX2 在癌症干性中的作用：肿瘤恶性程度和治疗潜力。

J Mol Cell Biol. 2020 Feb 20;12(2):85-98. doi: 10.1093/jmcb/mjy080.

4

SOX2 in development and cancer biology.发育与癌症生物学中的SOX2

Semin Cancer Biol. 2020 Dec;67(Pt 1):74-82. doi: 10.1016/j.semcancer.2019.08.007. Epub 2019 Aug 11.

5

Arsenic trioxide regulates the apoptosis of glioma cell and glioma stem cell via down-regulation of stem cell marker Sox2.三氧化二砷通过下调干细胞标志物 Sox2 调节神经胶质瘤细胞和神经胶质瘤干细胞的凋亡。

Biochem Biophys Res Commun. 2011 Jul 8;410(3):692-7. doi: 10.1016/j.bbrc.2011.06.060. Epub 2011 Jun 15.

6

Investigation of specific binding of designed oligodeoxynucleotide decoys to transcription factors in HT29 cell line undergoing epithelial-mesenchymal transition (EMT).在经历上皮-间充质转化（EMT）的 HT29 细胞系中，调查设计的寡脱氧核苷酸诱饵与转录因子的特异性结合。

J Cell Physiol. 2019 Dec;234(12):22765-22774. doi: 10.1002/jcp.28841. Epub 2019 May 21.

7

XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.XIAP 限制 Sox2 的自噬降解，是鼻咽癌干细胞的治疗靶点。

Theranostics. 2018 Feb 5;8(6):1494-1510. doi: 10.7150/thno.21717. eCollection 2018.

8

Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.PI3K和SOX2对头颈部鳞状细胞癌干细胞的调控

J Natl Cancer Inst. 2016 Sep 15;109(1). doi: 10.1093/jnci/djw189. Print 2017 Jan.

9

GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.GSKJ4，一种H3K27me3去甲基化酶抑制剂，能有效抑制乳腺癌干细胞。

Exp Cell Res. 2017 Oct 15;359(2):405-414. doi: 10.1016/j.yexcr.2017.08.024. Epub 2017 Aug 18.

10

Antitumor DNA vaccination against the Sox2 transcription factor.针对Sox2转录因子的抗肿瘤DNA疫苗接种

Int J Oncol. 2014 Jul;45(1):139-46. doi: 10.3892/ijo.2014.2402. Epub 2014 Apr 28.

引用本文的文献

1

Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate Cancer.前列腺癌中神经内分泌转分化驱动因子的治疗性利用

Cells. 2024 Dec 3;13(23):1999. doi: 10.3390/cells13231999.

2

Dexamethasone-tamoxifen combination exerts synergistic therapeutic effects in tamoxifen-resistance breast cancer cells.地塞米松-他莫昔芬联合用药对他莫昔芬耐药乳腺癌细胞发挥协同治疗作用。

Biosci Rep. 2024 Jul 31;44(7). doi: 10.1042/BSR20240367.

3

Cross-Talks between Raf Kinase Inhibitor Protein and Programmed Cell Death Ligand 1 Expressions in Cancer: Role in Immune Evasion and Therapeutic Implications.

本文引用的文献

1

The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells.FBXW2-MSX2-SOX2 轴调节干细胞特性和癌细胞的耐药性。

Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20528-20538. doi: 10.1073/pnas.1905973116. Epub 2019 Sep 23.

2

SOX2 in development and cancer biology.发育与癌症生物学中的SOX2

Semin Cancer Biol. 2020 Dec;67(Pt 1):74-82. doi: 10.1016/j.semcancer.2019.08.007. Epub 2019 Aug 11.

3

Proteolysis of methylated SOX2 protein is regulated by L3MBTL3 and CRL4 ubiquitin ligase.组蛋白甲基化 SOX2 蛋白的蛋白水解受到 L3MBTL3 和 CRL4 泛素连接酶的调控。

Raf 激酶抑制剂蛋白与程序性细胞死亡配体 1 表达在癌症中的串扰：在免疫逃逸中的作用和治疗意义。

Cells. 2024 May 17;13(10):864. doi: 10.3390/cells13100864.

4

Protein neddylation and its role in health and diseases.蛋白质的类泛素化及其在健康和疾病中的作用。

Signal Transduct Target Ther. 2024 Apr 5;9(1):85. doi: 10.1038/s41392-024-01800-9.

5

STIM1/SOX2 proteins are co-expressed in the tumor and microenvironmental stromal cells of pancreatic ductal adenocarcinoma and ampullary carcinoma.STIM1/SOX2 蛋白在胰腺导管腺癌和壶腹癌的肿瘤和微环境基质细胞中共同表达。

World J Surg Oncol. 2024 Mar 26;22(1):84. doi: 10.1186/s12957-024-03356-y.

6

Potential Alternative Therapeutic Modalities for Management Head and Neck Squamous Cell Carcinoma: A Review.治疗头颈部鳞状细胞癌的潜在替代治疗方法：综述。

Cancer Control. 2023 Jan-Dec;30:10732748231185003. doi: 10.1177/10732748231185003.

7

The DNA binding high mobility group box protein family functionally binds RNA.DNA 结合高迁移率族盒蛋白家族具有结合 RNA 的功能。

Wiley Interdiscip Rev RNA. 2023 Sep-Oct;14(5):e1778. doi: 10.1002/wrna.1778. Epub 2023 Jan 16.

8

Maintaining Myofibroblastic-Like Cancer-Associated Fibroblasts by Cancer Stemness Signal Transduction Feedback Loop.通过癌症干性信号转导反馈环维持肌成纤维细胞样癌症相关成纤维细胞

Cureus. 2022 Sep 20;14(9):e29354. doi: 10.7759/cureus.29354. eCollection 2022 Sep.

9

Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance.细胞凋亡失调与癌症多药耐药性的发展

Cancers (Basel). 2021 Aug 28;13(17):4363. doi: 10.3390/cancers13174363.

10

Unfavorable Prognostic Effects of the Stem Cell Pluripotency Factor Sox2 in Feline Invasive Mammary Carcinomas.干细胞多能性因子Sox2在猫浸润性乳腺癌中的不良预后影响

Front Vet Sci. 2021 Jan 22;7:622019. doi: 10.3389/fvets.2020.622019. eCollection 2020.

J Biol Chem. 2019 Jan 11;294(2):476-489. doi: 10.1074/jbc.RA118.005336. Epub 2018 Nov 15.

4

Dynamic ubiquitylation of Sox2 regulates proteostasis and governs neural progenitor cell differentiation.Sox2 的动态泛素化调节蛋白质稳态并控制神经祖细胞分化。

Nat Commun. 2018 Nov 7;9(1):4648. doi: 10.1038/s41467-018-07025-z.

5

Targeting SOX2 in anticancer therapy.靶向 SOX2 在癌症治疗中的应用。

Expert Opin Ther Targets. 2018 Dec;22(12):983-991. doi: 10.1080/14728222.2018.1538359. Epub 2018 Oct 26.

6

Protein neddylation and its alterations in human cancers for targeted therapy.蛋白质类泛素化及其在人类癌症中的改变用于靶向治疗。

Cell Signal. 2018 Apr;44:92-102. doi: 10.1016/j.cellsig.2018.01.009. Epub 2018 Jan 10.

7

The dark side of SOX2: cancer - a comprehensive overview.SOX2的阴暗面：癌症——全面概述

Oncotarget. 2017 Jul 4;8(27):44917-44943. doi: 10.18632/oncotarget.16570.

8

Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival.SOX2的下调是三苯甲烷龙胆紫对黑色素瘤细胞自我更新和存活抑制作用的基础。

J Invest Dermatol. 2016 Oct;136(10):2059-2069. doi: 10.1016/j.jid.2016.06.610. Epub 2016 Jun 29.

9

SIRT1-mediated transcriptional regulation of SOX2 is important for self-renewal of liver cancer stem cells.SIRT1 介导的 SOX2 转录调控对于肝癌干细胞的自我更新很重要。

Hepatology. 2016 Sep;64(3):814-27. doi: 10.1002/hep.28690. Epub 2016 Jul 18.

10

MSX2 mediates entry of human pluripotent stem cells into mesendoderm by simultaneously suppressing SOX2 and activating NODAL signaling.MSX2通过同时抑制SOX2并激活NODAL信号传导，介导人类多能干细胞进入中胚层内胚层。

Cell Res. 2015 Dec;25(12):1314-32. doi: 10.1038/cr.2015.118. Epub 2015 Oct 2.